Mounjaro®
Starting from £179.99/mo
Start journey Learn moreB6 injections for weight loss have been promoted in some private clinics for years, but the clinical picture is less flattering than the marketing. Vitamin B6 (pyridoxine) is an essential nutrient involved in metabolism and neurotransmitter production — however, there is no robust clinical evidence that injecting it produces meaningful weight loss in people who are not deficient in it. What does have a substantial, peer-reviewed evidence base are the licensed GLP-1 medicines, which work through a completely different mechanism and are the treatments a prescriber can legally offer you for weight management in the UK today. Understanding the difference matters before you book a session or hand over money for something that falls outside the regulated medicine framework.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The appeal is understandable. B6 is involved in the metabolism of proteins, fats and carbohydrates, and some clinics extrapolate from that biochemistry to the idea that injecting it will accelerate fat burning. It sounds plausible. The problem is that plausible mechanism does not equal clinical effect. The body tightly regulates its B6 status, and once tissue needs are met, additional pyridoxine is excreted rather than converted into a metabolic accelerator. In people who are replete (which is the majority of adults eating a varied diet) B6 injections add nothing metabolically useful.
B6 is sometimes combined with B12 and other compounds in what clinics call "lipotropic" or "MIC" injections. These cocktails are similarly unlicensed for weight loss and similarly unsupported by controlled trial data. If you are researching injections marketed as fat-burning treatments, the pattern repeats: clinics lean on biochemical rationale; the trials simply aren't there. The same scepticism applies if you have come across the M injection for weight loss, which follows a similarly familiar pattern of bold claims and limited clinical backing.
Being sceptical about this is rational, not cynical. Vitamin B6 toxicity (peripheral neuropathy, sensory disturbance) has been documented with high-dose supplementation. Injecting any substance carries infection risk at the site. Neither risk is justified where the therapeutic benefit is undemonstrated.
Most people searching for B6 injections are really asking a bigger question: is there an injection that will help me lose weight meaningfully and safely? That is a reasonable thing to want, and the answer is yes, but it isn't B6. The two licensed injectable weight-loss medicines in the UK are tirzepatide (sold as Mounjaro) and semaglutide (sold as Wegovy). Both are Prescription-Only Medicines, meaning a prescriber must assess your health, weight and history before issuing a prescription. There is no legal shortcut around that stage.
Tirzepatide works as a dual GIP and GLP-1 receptor agonist, slowing gastric emptying and reducing appetite through two gut-hormone pathways simultaneously. In the SURMOUNT-1 clinical trial, participants at the highest dose lost an average of around 20–21% of their body weight over 72 weeks, figures published in the New England Journal of Medicine and reviewed by NICE as part of its December 2024 recommendation. Semaglutide (Wegovy) produced around 15% average reduction in the STEP 1 trial. Neither outcome is achievable with a vitamin injection. The decision, then, is not really "B6 or GLP-1", it is whether to pursue a licensed, clinically reviewed pathway or an unlicensed one with no trial evidence behind it.
You can read more about how these treatments compare on our weight-loss injections overview.
The licensed eligibility criteria for Mounjaro and Wegovy are straightforward in outline, though only a prescriber can apply them to your individual situation. Adults with a BMI of 30 or above qualify on BMI alone; a BMI of 27 or above qualifies if accompanied by at least one weight-related health condition such as high blood pressure, high cholesterol, prediabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance, details are on our eligibility page.
At nume, the process starts with a free consultation, no GP referral, no waiting list. A GPhC-registered Independent Prescriber reads your answers the same day. Identity and weight are verified; your GP is notified in line with GPhC guidance. If treatment is clinically suitable and you order before noon on a working day, your prescription is dispatched the same day and arrives with DPD the next working day in plain, unbranded packaging. The pen goes straight in the fridge door when it arrives. Everything (consultation, prescription, delivery, and 7-day aftercare) is included in one transparent price with no subscription.
You can find current pricing information and treatment options on our treatment page. Our clinical team oversees every consultation.
If a clinic or online seller is offering B6 injections specifically for weight loss without a medical assessment, that is worth pausing on, not because B6 is a controlled substance, but because it signals that the seller's standards for evidence and clinical oversight are low. The same applies to unlicensed "lipotropic" cocktails, and it is worth noting that men researching their options can find a dedicated breakdown of the evidence and eligibility considerations on our page covering weight loss injections for men. The MHRA has a Yellow Card reporting tool for suspected adverse reactions and for flagging sellers of suspect products.
For the licensed GLP-1 medicines, sourcing matters enormously. Counterfeit tirzepatide and semaglutide pens have appeared in the UK, some containing insulin, which has caused serious harm. Before buying from any online pharmacy, verify it on the GPhC pharmacy register. nume's GPhC premises registration is 9012878, verifiable at that link. Genuine medicines, a real prescriber, and a pharmacy you can check, those are the criteria worth applying, not the price.
If you are curious about how licensed injections work in practice, including what the injection process involves, our guide to weight-loss injections covers the detail. Ready to find out whether you're eligible? Check your eligibility with a free consultation today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.